JPH0428686B2 - - Google Patents

Info

Publication number
JPH0428686B2
JPH0428686B2 JP56061115A JP6111581A JPH0428686B2 JP H0428686 B2 JPH0428686 B2 JP H0428686B2 JP 56061115 A JP56061115 A JP 56061115A JP 6111581 A JP6111581 A JP 6111581A JP H0428686 B2 JPH0428686 B2 JP H0428686B2
Authority
JP
Japan
Prior art keywords
deazaadenosine
acid
formulation according
inflammation
inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP56061115A
Other languages
English (en)
Japanese (ja)
Other versions
JPS56166118A (en
Inventor
Binegaa Rarufu
Uorubaagu Jerarudo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of JPS56166118A publication Critical patent/JPS56166118A/ja
Publication of JPH0428686B2 publication Critical patent/JPH0428686B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052Imidazole radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP6111581A 1980-04-23 1981-04-22 Antiinflammatory Granted JPS56166118A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8013411A GB2074858B (en) 1980-04-23 1980-04-23 Compositions containing 3-deazaaden-osine

Publications (2)

Publication Number Publication Date
JPS56166118A JPS56166118A (en) 1981-12-21
JPH0428686B2 true JPH0428686B2 (en, 2012) 1992-05-15

Family

ID=10512973

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6111581A Granted JPS56166118A (en) 1980-04-23 1981-04-22 Antiinflammatory

Country Status (15)

Country Link
EP (1) EP0038567B1 (en, 2012)
JP (1) JPS56166118A (en, 2012)
AU (1) AU553680B2 (en, 2012)
BE (1) BE888525A (en, 2012)
CA (1) CA1172168A (en, 2012)
CH (1) CH654316A5 (en, 2012)
DE (2) DE3116029A1 (en, 2012)
DK (1) DK179781A (en, 2012)
GB (1) GB2074858B (en, 2012)
IE (2) IE51738B1 (en, 2012)
IL (1) IL62696A (en, 2012)
IT (1) IT1170910B (en, 2012)
NL (1) NL8101987A (en, 2012)
NZ (1) NZ196883A (en, 2012)
ZA (1) ZA812640B (en, 2012)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU596637B2 (en) * 1986-08-06 1990-05-10 Sumitomo Chemical Company, Limited Mulching film for repelling insect pests
US4918060A (en) * 1987-09-04 1990-04-17 The Johns Hopkins University Method of treating myasthenia gravis and related diseases
US5137876A (en) * 1990-10-12 1992-08-11 Merck & Co., Inc. Nucleoside antiviral and anti-inflammatory compounds and compositions and methods for using same
US5698533A (en) * 1994-07-26 1997-12-16 Kang; Meng-Che Ophthalmic pharmaceutical composition
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US6515016B2 (en) * 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
EP1107765B1 (en) * 1998-09-03 2006-08-09 Kerckhoff-Klink Gesellschaft mit Beschrankter Haftung 3-deazaadenosine used in the prevention of atherosclerosis and graft vasculopathy
JP2002274626A (ja) * 2001-03-19 2002-09-25 Okamura Corp ローラコンベヤ装置

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4148888A (en) * 1978-03-13 1979-04-10 The United States Of America As Represented By The Department Of Health, Education And Welfare 3-Deazaadenosine as an inhibitor of adenosylhomocysteine hydrolase with antiviral activity
EP0010668B1 (en) * 1978-10-13 1986-01-22 The Wellcome Foundation Limited 3-deazaadenosine and pharmaceutical compositions containing it

Also Published As

Publication number Publication date
NL8101987A (nl) 1981-11-16
AU553680B2 (en) 1986-07-24
ZA812640B (en) 1982-12-29
IE811594L (en) 1981-10-23
CA1172168A (en) 1984-08-07
NZ196883A (en) 1984-07-31
IL62696A0 (en) 1981-06-29
EP0038567B1 (en) 1987-09-23
DE3116029C2 (en, 2012) 1991-01-17
DE3116029A1 (de) 1982-03-18
EP0038567A1 (en) 1981-10-28
CH654316A5 (de) 1986-02-14
IT1170910B (it) 1987-06-03
IL62696A (en) 1984-03-30
AU6971081A (en) 1981-10-29
BE888525A (fr) 1981-10-22
DE3176462D1 (en) 1987-10-29
GB2074858B (en) 1985-03-20
JPS56166118A (en) 1981-12-21
IT8148327A0 (it) 1981-04-22
IE810891L (en) 1981-10-23
GB2074858A (en) 1981-11-11
IE51737B1 (en) 1987-03-18
DK179781A (da) 1981-10-24
IE51738B1 (en) 1987-03-18

Similar Documents

Publication Publication Date Title
US4322411A (en) Anti-inflammatory nucleosides
US5401777A (en) Use of preparations of curcuma plants
US6054486A (en) Use of 9-Deoxy-2',9-α-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen e)-13,14-dihydro-prostaglandin f1 to treat peripheral vascular disease
KR100464693B1 (ko) 5-메틸이소옥사졸-4-카복실산-(4-트리플루오로메틸)-아닐리드와n-(4-트리플루오로메틸페닐)-2-시아노-3-하이드록시크로톤산아미드와의배합물을함유하는제제
KR101996245B1 (ko) 선택적 s1p1 수용체 아고니스트를 포함하는 약학 조합물
EP0811623A1 (de) Xanthinverbindungen mit terminal aminierten Alkinol-Seitenketten
AU740875B2 (en) Novel use of compounds for anti-pruritic activity
US20110275577A1 (en) Methods of treating dermatologic, gynecologic, and genital disorders with caffeic acid analogs
PT98731B (pt) Processo para a preparacao de um sal de codeina de um acido carboxilico substituido
US4144332A (en) Process for alleviating proliferative skin diseases
JPH0428686B2 (en, 2012)
JPH0134970B2 (en, 2012)
EP0448029B1 (en) Novel pharmaceutical uses of forskolin derivatives
US4146621A (en) Process of treating proliferative skin diseases
JP2003531113A (ja) 皮脂腺障害のためのコレステロールエステルとワックスエステルの合成の二重阻害剤
KR20150095773A (ko) 건선 치료를 위한 피도티모드의 사용
JPS60158149A (ja) 炎症抑制作用を有する1,4‐ナフトキノン誘導体
JPS6245525A (ja) 脂質低下剤
US4161525A (en) Process of treating proliferative skin diseases with indole derivatives
EP0338010B1 (en) Pharmaceutical compositions for treatment of hyperproliferate skin disease
US4113870A (en) Method for treatment of hypertension
EP0337739A2 (en) Use of TP-receptor antagonists to modify the action of myofibroblasts
JPH0395116A (ja) 逆転写酵素阻害組成物
Murphy Drug Profile: Benoral
US4481210A (en) Method of treatment